Literature DB >> 17109113

[Importance of intrathecal pain therapy].

R Likar1, W Ilias, H Kloimstein, A Kofler, H G Kress, J Neuhold, M M Pinter, M C Spendel.   

Abstract

Intraspinal drug infusion using implantable pumps and catheter systems is a safe and effective therapy for selected pain patients with severe chronic pain. It improves pain relief, reduces drug-related side effects, decreases the need for oral analgesia and enhances quality of life in a segment of chronic pain patients whose pain has not been controlled with more conservative therapies. Intrathecal drug therapy has therefore established its role in the treatment of malignant pain, benign pain and severe spasticity.Careful patient selection and management as well as a multidisciplinary approach are determinants of successful treatment. Current practices for patient selection and management, screening, drug selection, dosing and implantation for intrathecal drug delivery systems are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17109113     DOI: 10.1007/s00482-006-0515-2

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  35 in total

1.  Current practices in intraspinal therapy--a survey of clinical trends and decision making.

Authors:  S J Hassenbusch; R K Portenoy
Journal:  J Pain Symptom Manage       Date:  2000-08       Impact factor: 3.612

2.  Efficacy of intrathecal bupivacaine: how important is the flow rate?

Authors:  Eric Buchser; Anne Durrer; Dominique Chédel; Jean-Pierre Mustaki
Journal:  Pain Med       Date:  2004-09       Impact factor: 3.750

3.  Intraspinal morphine for chronic pain: a retrospective, multicenter study.

Authors:  J A Paice; R D Penn; S Shott
Journal:  J Pain Symptom Manage       Date:  1996-02       Impact factor: 3.612

4.  Spinal cord compression complicating subarachnoid infusion of morphine: case report and laboratory experience.

Authors:  R B North; P N Cutchis; J A Epstein; D M Long
Journal:  Neurosurgery       Date:  1991-11       Impact factor: 4.654

5.  Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology.

Authors:  M Winkelmüller; W Winkelmüller
Journal:  J Neurosurg       Date:  1996-09       Impact factor: 5.115

6.  Analgesia mediated by a direct spinal action of narcotics.

Authors:  T L Yaksh; T A Rudy
Journal:  Science       Date:  1976-06-25       Impact factor: 47.728

7.  [Continuous administration of opiates with implantable drug delivery systems in patients with intractable non-malignant pain.].

Authors:  M Winkelmüller; W Winkelmüller
Journal:  Schmerz       Date:  1991-03       Impact factor: 1.107

8.  Intrathecal infusion systems for treatment of chronic low back and leg pain of noncancer origin.

Authors:  U Tutak; D M Doleys
Journal:  South Med J       Date:  1996-03       Impact factor: 0.954

9.  Catheter-associated masses in patients receiving intrathecal analgesic therapy.

Authors:  Marion R McMillan; Thomas Doud; W Nugent
Journal:  Anesth Analg       Date:  2003-01       Impact factor: 5.108

10.  Making a case for programmable pumps over fixed rate pumps for the management of fluctuations in chronic pain and spasticity: a literature review.

Authors:  N G Rainov; E Buchser
Journal:  Neuromodulation       Date:  2002-04
View more
  7 in total

1.  [Treatment of chronic pain. Selected interventional methods].

Authors:  M Zenz
Journal:  Anaesthesist       Date:  2011-11       Impact factor: 1.041

2.  [Withdrawal in a patient with an implantable drug delivery system in spite of continuation of opiate therapy].

Authors:  S Lochner; U Heinrich-Gräfe; W Kirch
Journal:  Internist (Berl)       Date:  2010-05       Impact factor: 0.743

3.  [Perispinal pain therapy. How invasive should we be?].

Authors:  F Elsner; L Radbruch
Journal:  Schmerz       Date:  2007-02       Impact factor: 1.107

4.  [Risk minimization in pain therapy: important target but how can it be reached?].

Authors:  G-G Hanekop; F B M Ensink
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

5.  [Addition is also a disease].

Authors:  C Maier
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

Review 6.  [Selected interventional methods for the treatment of chronic pain : part 2: regional anesthetic techniques close to the spinal cord and neuromodulative methods].

Authors:  E Böttger; K Diehlmann
Journal:  Anaesthesist       Date:  2011-06       Impact factor: 1.041

7.  [Risk assessment in pain therapy].

Authors:  D Schoeffel; H R Casser; M Bach; H G Kress; R Likar; H Locher; W Steinleitner; M Strohmeier; H Brunner; R D Treede; W Zieglgänsberger; J Sandkühler
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.